Medicine Description mabthera 500mg
Mabthera 500mg Vial is a medication that contains rituximab, a monoclonal antibody designed to bind specifically to the CD20 antigen present on the surface of B cells. By targeting these cells, Mabthera induces several mechanisms of action, including antibody-dependent cellular cytotoxicity (ADCC), complement-dependent cytotoxicity (CDC), and direct apoptosis of B cells. This targeted action reduces the population of both malignant and normal B cells, leading to a decrease in inflammation associated with immune-mediated diseases and the suppression of tumor growth in certain hematological cancers.
Indications and Uses of Mabthera 500mg Vial
- Non-Hodgkin Lymphoma
- Chronic Lymphocytic Leukemia
- Rheumatoid Arthritis
- Granulomatosis with Polyangiitis
- Pemphigus Vulgaris
- Wegener's Granulomatosis
- Other CD20-positive malignancies
Side Effects of Mabthera 500mg Vial
- Infusion-related reactions
- Increased risk of infections
- Hypotension
- Fever and chills
- Nausea
- Fatigue
- Rash
- Headache
Storage and Handling
Mabthera should be stored in a refrigerator at a temperature between 2°C and 8°C (36°F to 46°F). It must not be frozen, and any unused product should be discarded after its expiration date.
Patient Advice and Precautions
Patients receiving Mabthera should be closely monitored for infusion-related reactions, particularly during the first administration. It is essential to inform healthcare providers about any history of allergic reactions and current medications to avoid potential interactions. Regular blood tests are necessary to monitor for any adverse effects on blood cell counts and immune function.